BackgroundCheck.run
Search For

Maureen M Mckenna, 64185 Chilton Ave, San Francisco, CA 94131

Maureen Mckenna Phones & Addresses

185 Chilton Ave, San Francisco, CA 94131    415-4528148   

121 Moffitt St, San Francisco, CA 94131    415-6646806   

1175 Clayton St #6, San Francisco, CA 94117    415-4528148   

New York, NY   

1933 Grant St, Berkeley, CA 94703   

185 Chilton Ave, San Francisco, CA 94131    707-6887271   

Work

Position: Professional/Technical

Education

Degree: Graduate or professional degree

Emails

Mentions for Maureen M Mckenna

Career records & work history

Medicine Doctors

Maureen L. Mckenna

Specialties:
Pediatrics, Adolescent Medicine
Work:
Washingtonville Pediatrics
10 Weathervane Dr, Washingtonville, NY 10992
845-4965437 (phone) 845-4967640 (fax)
Site
Education:
Medical School
University of Texas Medical School at Houston
Graduated: 2007
Conditions:
Acute Pharyngitis, Acute Sinusitis, Anemia, Anxiety Phobic Disorders, Atopic Dermatitis, Attention Deficit Disorder (ADD), Constipation, Otitis Media, Plantar Warts, Viral Meningitis, Abdominal Hernia, Acute Bronchitis, Acute Conjunctivitis, Acute Upper Respiratory Tract Infections, Allergic Rhinitis, Autism, Bronchial Asthma, Burns, Congenital Anomalies of the Heart, Croup, Epilepsy, Hearing Loss, Infectious Mononucleosis, Inguinal Hernia, Iron Deficiency Anemia, Lyme Disease, Pneumonia, Skin and Subcutaneous Infections, Urinary Incontinence
Languages:
English
Description:
Dr. Mckenna graduated from the University of Texas Medical School at Houston in 2007. She works in Washingtonville, NY and specializes in Pediatrics and Adolescent Medicine. Dr. Mckenna is affiliated with Orange Regional Medical Center.

License Records

Maureen T Mckenna

Licenses:
License #: RN15823 - Active
Category: Nursing
Issued Date: Dec 28, 1970
Expiration Date: Mar 1, 2019
Type: Registered Nurse

Publications & IP owners

Us Patents

2-Amino-7,8-Dihydro-6H-Pyrido[4,3-D]Pyrimidin-5-Ones

US Patent:
7671059, Mar 2, 2010
Filed:
Sep 28, 2006
Appl. No.:
11/541462
Inventors:
Timothy D. Machajewski - Emeryville CA, US
Cynthia M. Shafer - Emeryville CA, US
Christopher McBride - Emeryville CA, US
Brandon M. Doughan - Emeryville CA, US
Barry H. Levine - Emeryville CA, US
Yi Xia - Emeryville CA, US
Maureen McKenna - Emeryville CA, US
Kris Mendenhall - Emeryville CA, US
Yasheen Zhou - Emeryville CA, US
Kristin Brinner - Emeryville CA, US
Zhenhai Gao - Emeryville CA, US
Daniel Poon - Emeryville CA, US
Paul Barsanti - Emeryville CA, US
Xiaodong Lin - Emeryville CA, US
Abran Costales - Emeryville CA, US
Alice Rico - Emeryville CA, US
Nathan Brammeier - Emeryville CA, US
Teresa Pick - Emeryville CA, US
Paul A. Renhowe - Emeryville CA, US
Assignee:
Novartis AG - Basel
International Classification:
A61K 31/519
A61K 31/5355
C07D 471/04
C07D 487/04
C07D 413/06
A61P 35/00
US Classification:
51425505, 544279, 544117, 5142342, 546220, 546209, 560 42, 548204
Abstract:
Disclosed are 2-amino-7,8-dihydro-6H-pyrido[4,3-d]pyrimidin-5-one compounds, their stereoisomers, tautomers, pharmaceutically acceptable salts, and prodrugs thereof; compositions that include a pharmaceutically acceptable carrier and one or more of the 2-amino-7,8-dihydro-6H-pyrido[4,3-d]pyrimidin-5-one compounds, either alone or in combination with at least one additional therapeutic agent. Disclosed also are methods of using the 2-amino-7,8-dihydro-6H-pyrido[4,3-d]pyrimidin-5-one compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of cellular proliferative, viral, autoimmune, cardiovascular, and central nervous system diseases.

Heteroaryl-Substituted Imidazole Compounds And Uses Thereof

US Patent:
8129394, Mar 6, 2012
Filed:
Mar 19, 2009
Appl. No.:
12/383035
Inventors:
Zilin Hunag - San Leandro CA, US
Jeff Jin - San Ramon CA, US
Timothy Machajewski - Martinez CA, US
Maureen McKenna - Pinole CA, US
Daniel Poon - Piedmont CA, US
Paul A. Renhowe - Emeryville CA, US
Martin Sendzik - San Mateo CA, US
Cynthia Shafer - Moraga CA, US
Aaron Smith - Union City CA, US
Yongjin Xu - Castro Valley CA, US
Qiong Zhang - Union City CA, US
Zheng Chen - Fremont CA, US
Assignee:
Novartis AG - Basel
International Classification:
A61K 31/4965
A61K 31/505
A01N 43/54
C07D 403/00
C07D 401/00
C07D 405/00
C07D 409/00
C07D 411/00
C07D 413/00
C07D 417/00
C07D 419/00
US Classification:
51425505, 514275, 544295, 544331
Abstract:
Novel imidazole compounds of the general formula.

2-Amino-Quinazolin-5-Ones

US Patent:
2007002, Feb 1, 2007
Filed:
Apr 14, 2006
Appl. No.:
11/404372
Inventors:
Cornelia Bellamacina - Castro Valley CA, US
Abran Costales - El Cerrito CA, US
Brandon Doughan - Eugene OR, US
Susan Fong - Richmond CA, US
Zhenhai Gao - Hercules CA, US
Thomas Hendrickson - Encinitas CA, US
Barry Levine - Lafayette CA, US
Xiaodong Lin - Walnut Creek CA, US
Timothy Machajewski - Martinez CA, US
Christopher McBride - Oakland CA, US
Maureen McKenna - Pinole CA, US
Kris Mendenhall - Concord CA, US
Alice Rico - Castro Valley CA, US
Cynthia Shafer - Moraga CA, US
Yi Xia - Foster City CA, US
Yasheen Zhou - Moraga CA, US
International Classification:
A61K 31/5377
A61K 31/517
C07D 413/02
C07D 403/02
US Classification:
514234200, 544123000, 544284000, 514252170, 514255050, 514266200, 514266220
Abstract:
2-Amino-quinazolin-5-one compounds, stereoisomers, tautomers, pharmaceutically acceptable salts, and prodrugs thereof; compositions that include a pharmaceutically acceptable carrier and one or more of the 2-amino-quinazolin-5-one compounds, either alone or in combination with at least one additional therapeutic agent. Methods of using the 2-amino-quinazolin-5-one compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of cell proliferative diseases.

2-Amino-7,8-Dihydro-6H-Pyrido[4,3-D]Pyrimidin-5-Ones

US Patent:
2010000, Jan 7, 2010
Filed:
Jul 31, 2009
Appl. No.:
12/462302
Inventors:
Cynthia M. Shafer - Emeryville CA, US
Christopher McBride - Emeryville CA, US
Brandon M. Doughan - Emeryville CA, US
Barry H. Levine - Emeryville CA, US
Yi Xia - Emeryville CA, US
Maureen McKenna - Emeryville CA, US
Kris Mendenhall - Emeryville CA, US
Yasheen Zhou - Emeryville CA, US
Baoqing Gong - Emeryville CA, US
Dan Gu - Emeryville CA, US
John Dolan - Emeryville CA, US
John Tulinsky - Emeryville CA, US
Kristin Brinner - Emeryville CA, US
Zhenhai Gao - Emeryville CA, US
Daniel Poon - Emeryville CA, US
Paul Barsanti - Emeryville CA, US
Xiaodong Lin - Emeryville CA, US
Abran Costales - Emeryville CA, US
Alice Rico - Emeryville CA, US
Nathan Brammeier - Emeryville CA, US
Teresa Pick - Emeryville CA, US
Paul A. Renhowe - Emeryville CA, US
International Classification:
C07D 471/04
A61K 31/5377
A61K 31/497
A61K 31/519
US Classification:
5142342, 51425505, 51426411, 544117, 544279, 546243
Abstract:
Disclosed are 2-amino-7,8-dihydro-6H-pyrido[4,3-d]pyrimidin-5-one compounds, their stereoisomers, tautomers, pharmaceutically acceptable salts, and prodrugs thereof; compositions that include a pharmaceutically acceptable carrier and one or more of the 2-amino-7,8-dihydro-6H-pyrido[4,3-d]pyrimidin-5-one compounds, either alone or in combination with at least one additional therapeutic agent. Disclosed also are methods of using the 2-amino-7,8-dihydro-6H-pyrido[4,3-d]pyrimidin-5-one compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of cellular proliferative, viral, autoimmune, cardiovascular, and central nervous system diseases.

Novel Heterocyclic Compounds And Uses Thereof

US Patent:
2013021, Aug 15, 2013
Filed:
Feb 14, 2012
Appl. No.:
13/396339
Inventors:
Zilin Huang - San Leandro CA, US
Jeff Jin - San Ramon CA, US
Timothy Machajewski - Martinez CA, US
Maureen McKenna - Pinole CA, US
Daniel Poon - Piedmont CA, US
Paul A. Renhowe - Emeryville CA, US
Martin Sendzik - San Mateo CA, US
Cynthia Shafer - Moraga CA, US
Aaron Smith - Union City CA, US
Yongjin Xu - Castro Valley CA, US
Qiong Zhang - Union City CA, US
Zheng Chen - Fremont CA, US
International Classification:
A61K 31/444
A61K 31/506
C07D 403/14
C07D 405/14
A61K 31/4439
C07D 417/14
C07D 471/04
C07D 413/14
A61K 31/496
C07D 487/04
A61K 31/4985
C07D 498/04
A61K 31/5383
A61K 31/4709
A61K 31/5377
A61P 35/00
C07D 401/14
US Classification:
5142305, 546256, 514333, 544331, 514275, 544295, 51425505, 5462741, 514341, 5462697, 546113, 514300, 5462714, 544364, 51425218, 5462757, 514338, 5462721, 546122, 546119, 544350, 514249, 514303, 546121, 544105, 546167, 514314, 544122, 5142358, 514342, 514340
Abstract:
New substituted heterocyclic compounds, compositions containing them, and methods of using them for the inhibition of Raf kinase activity are provided. The new compounds and compositions may be used either alone or in combination with at least one additional agent for the treatment of a Raf kinase mediated disorder, such as cancer.

Process For The Preparation Of Tetraethyl Methylenebisphosphonate

US Patent:
5688983, Nov 18, 1997
Filed:
Mar 12, 1996
Appl. No.:
8/614234
Inventors:
Michael R. Leadbetter - San Leandro CA
Richard W. Brown - Moraga CA
Maureen M. McKenna - Alameda CA
Assignee:
Zeneca Limited - London
International Classification:
C07F 940
US Classification:
558136
Abstract:
This invention relates to a process for the preparation of tetraethyl methylenebisphosphonate by the reaction of dichloromethane with diethyl phosphite, wherein the reaction is performed in a polar aprotic solvent or mixtures thereof.

Isbn (Books And Publications)

Emil Armin, 1883-1971: Illinois State Museum, Springfield, April 27 - June 8, 1980

Author:
Maureen A. McKenna
ISBN #:
0897920872

Julia Thecla

Author:
Maureen A. McKenna
ISBN #:
0897921089

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.